Ovid Therapeutics Announces First Patient Randomized in Pivotal Phase 3 NEPTUNE Trial of OV101 for the Treatment of Angelman Syndrome

September 12, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search